Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a globally operating Finnish company which develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients for global markets. All of the company's manufacturing sites and the majority of its R&D units are in Finland.[2]
Orion's class A and B shares are listed on the Helsinki Stock Exchange.
History
Orion was founded on September 21, 1917 by pharmacists Onni Turpeinen, Eemil Tuurala and Wikki Valkama. Before founding Orion, they worked in a pharmaceutical-chemical factory called Medica. The first premises of the new company were found in a courtyard building in Helsinki's Kruununhaka, Mariankatu 24, i.e. Asunto Oy Mars star. Among the first products of the apothecary were Ballistol gun oil and dulcine.[3] Pediatrician Arvo Ylppö played a significant role starting in the 1920s.[4]
Orion's diagnostics business was previously concentrated in the Orion Diagnostica profit unit, which was sold to a private equity investor in April 2018.[5] The diagnostics business included the development, manufacture and marketing of diagnostic tests and hygiene tests. Orion Diagnostica changed its name in November 2019 and is now Aidian.[6]
Notable products
The following are Orion's top-selling product lines as of March 2021.[7]
External links
References
- Orion Group - Financial Statement Release 2021^
- About Orion^
- Orionin virstanpylväitä 1910-luvulla www.orion.fi, retrieved 2022-07-25^
- Orionin vahva mies www.ylppo.fi, retrieved 2022-07-25^
- Mark Moran. AJP Board Member Responds to NYT Story On Antidepressant Withdrawal Psychiatric News, 2018-05-18^
- Orion Diagnostica on nyt Aidian Aidian, retrieved 2022-07-25^
- Orion Result Presentation 1−3/2021^
- Orion Oyj Business Information System, Finnish Patent and Registration Office and Finnish Tax Administration, retrieved 22 October 2019^
- Yhtiöjärjestys Orion Oyj, 22 March 2017, retrieved 22 October 2019^